awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37666711-807BEE32-6E5C-44C8-AB69-BFCE4A52DAD4
Q37666711-807BEE32-6E5C-44C8-AB69-BFCE4A52DAD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37666711-807BEE32-6E5C-44C8-AB69-BFCE4A52DAD4
Pediatric Dosing and Body Size in Biotherapeutics.
P2860
Q37666711-807BEE32-6E5C-44C8-AB69-BFCE4A52DAD4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37666711-807BEE32-6E5C-44C8-AB69-BFCE4A52DAD4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e29543ce771455fe1f0250cad7c02f4752e2fb0a
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.